217 related articles for article (PubMed ID: 2607889)
1. Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats.
Soulban G; Labrecque G
Life Sci; 1989; 45(25):2485-9. PubMed ID: 2607889
[TBL] [Abstract][Full Text] [Related]
2. The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients.
Xi M; Béguin S; Hemker HC
Thromb Haemost; 1989 Sep; 62(2):788-91. PubMed ID: 2814925
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of blood coagulation.
Owren PA; Stormorken H
Ergeb Physiol; 1973; 68():1-53. PubMed ID: 4593726
[No Abstract] [Full Text] [Related]
4. Effect of warfarin on the kinetics of the vitamin K-dependent clotting factors in rats.
Vainieri H; Wingard LB
J Pharmacol Exp Ther; 1977 May; 201(2):507-17. PubMed ID: 870684
[TBL] [Abstract][Full Text] [Related]
5. Activation of human factor VII by activated factors IX and X.
Masys DR; Bajaj SP; Rapaport SI
Blood; 1982 Nov; 60(5):1143-50. PubMed ID: 7126868
[TBL] [Abstract][Full Text] [Related]
6. Effects of the hormones of the thyroid axis on the vitamin K-dependent plasma factors of blood coagulation (II, VII, IX, and X).
Negrev NN; Radev RZ; Velikova MS; Anogeianaki A
Int J Immunopathol Pharmacol; 2008; 21(1):221-6. PubMed ID: 18336749
[TBL] [Abstract][Full Text] [Related]
7. Self-damping mechanism in blood coagulation.
Nemerson Y; Silverberg SA; Jesty J
Thromb Diath Haemorrh; 1974 Sep; 32(1):57-64. PubMed ID: 4454045
[TBL] [Abstract][Full Text] [Related]
8. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
[TBL] [Abstract][Full Text] [Related]
9. Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA.
Gallistl S; Cvirn G; Leschnik B; Muntean W
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):653-5. PubMed ID: 12439153
[TBL] [Abstract][Full Text] [Related]
10. The normal coagulation mechanism.
Bennett B; Ratnoff OD
Med Clin North Am; 1972 Jan; 56(1):95-104. PubMed ID: 4550195
[No Abstract] [Full Text] [Related]
11. [Disseminated intravascular coagulation].
Amir J
Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
[No Abstract] [Full Text] [Related]
12. The role of serine proteases in the blood coagulation cascade.
Davie EW; Fujikawa K; Kurachi K; Kisiel W
Adv Enzymol Relat Areas Mol Biol; 1979; 48():277-318. PubMed ID: 367103
[No Abstract] [Full Text] [Related]
13. Somatotropin and somatostatin effects on vitamin K-dependent plasma coagulation factors.
Negrev N; Nyagolov Y; Stanchewa E
Eur J Pharmacol; 1995 Apr; 277(2-3):145-9. PubMed ID: 7493602
[TBL] [Abstract][Full Text] [Related]
14. [Influence of pregnancy on the activation factors of blood coagulation and on thrombocytes].
Tismer R; Egli H; Schander K
Z Geburtshilfe Perinatol; 1972 Jun; 176(3):183-92. PubMed ID: 5070000
[No Abstract] [Full Text] [Related]
15. The activation of factor IX by the tissue factor pathway.
Rapaport SI
Prog Clin Biol Res; 1981; 72():57-76. PubMed ID: 7335650
[No Abstract] [Full Text] [Related]
16. Decrease in blood coagulation factors II (prothrombin), VII, IX and X in the rat after a single oral dose of butylated hydroxytoluene.
Takahashi O
Food Chem Toxicol; 1987 Mar; 25(3):219-24. PubMed ID: 3570109
[TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Activation of coagulation in phospholipid phase].
Suzuki K
Rinsho Byori; 1985 Sep; 33(9):966-73. PubMed ID: 3878417
[No Abstract] [Full Text] [Related]
18. Coagulation protein function VII: diametric effects of acetaldehyde on factor VII and factor IX function.
Sabol DA; Basista MH; Brecher AS; Haider K; Kleshinski J
Dig Dis Sci; 1999 Dec; 44(12):2564-7. PubMed ID: 10630514
[TBL] [Abstract][Full Text] [Related]
19. Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans.
Kamali F; Edwards C; Wood P; Wynne HA; Kesteven P
Am J Hematol; 2001 Nov; 68(3):159-63. PubMed ID: 11754396
[TBL] [Abstract][Full Text] [Related]
20. The occurrence of beta-hydroxyaspartic acid in the vitamin K-dependent blood coagulation zymogens.
McMullen BA; Fujikawa K; Kisiel W
Biochem Biophys Res Commun; 1983 Aug; 115(1):8-14. PubMed ID: 6688526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
